Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.

by Delphine Vandame, Lauriane Ulmann, Marisa Teigell, Monica Prieto-Cappellini, Jacques Vignon, Alain Privat, Regino Perez-Polo, Olivera Nesic, Helene Hirbec
Published 2013-01-01